Enliven Therapeutics Inc. (ELVN) — Strategic Asset Allocation Index
Enliven Therapeutics Inc. (ELVN) has a Strategic Asset Allocation Index of 0.5% as of June 2023. Strategic assets (PP&E of $1.34 Million plus long-term investments of $-) total $1.34 Million, measured against net assets of $278.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ELVN net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Enliven Therapeutics Inc. Strategic Asset Allocation Index (2020–2021)
This chart shows how Enliven Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 0.5%, representing strategic assets of $1.34 Million against net assets of $278.99 Million USD. For live market cap and overall valuation, see market cap of Enliven Therapeutics Inc..
Annual Strategic Asset Allocation Index for Enliven Therapeutics Inc. (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Enliven Therapeutics Inc. from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ELVN net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.9% | $954.00K | $954.00K | $- | $106.86 Million | ▲ +0.4 pp |
| 2020 | 0.5% | $416.00K | $416.00K | $- | $84.44 Million | — |